Clinical Trial Update: Laquinimod Phase IIa Study in Active Crohn's Disease [Phase 2]

View source ↗

Summary

Laquinimod's Phase IIa study in active Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Laquinimod (laquinimod)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED